Molecular imaging using PET for breast cancer

被引：16

作者：

Kurihara, Hiroaki ^{[1
]}

Shimizu, Chikako ^{[2
]}

Miyakita, Yasuji ^{[3
]}

Yoshida, Masayuki ^{[4
]}

Hamada, Akinobu ^{[5
]}

Kanayama, Yousuke ^{[6
]}

Yonemori, Kan ^{[2
]}

Hashimoto, Jun ^{[2
]}

Tani, Hitomi ^{[1
]}

Kodaira, Makoto ^{[2
]}

Yunokawa, Mayu ^{[2
]}

Yamamoto, Harukaze ^{[2
]}

Watanabe, Yasuyoshi ^{[6
]}

Fujiwara, Yasuhiro ^{[2
]}

Tamura, Kenji ^{[2
]}

机构：

[1] Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo 1040045, Japan

[2] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo 1040045, Japan

[3] Natl Canc Ctr, Dept Neurosurg, Tokyo 1040045, Japan

[4] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo 1040045, Japan

[5] Natl Canc Ctr, Res Inst, Dept Clin Pharmacol Grp, Translat Res Support Core, Tokyo 104, Japan

[6] RIKEN, Ctr Mol Imaging Sci, Kobe, Hyogo, Japan

来源：

BREAST CANCER | 2016年 / 23卷 / 01期

关键词：

Breast cancer; PET; Molecular imaging; Molecular target therapy; HER2; POSITRON-EMISSION-TOMOGRAPHY; ESTROGEN-RECEPTOR; FDG-PET; WHOLE-BODY; NEOADJUVANT CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; F-18-FDG PET; TRASTUZUMAB; TUMOR; EXPRESSION;

D O I：

10.1007/s12282-015-0613-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Molecular imaging can visualize the biological processes at the molecular and cellular levels in vivo using certain tracers for specific molecular targets. Molecular imaging of breast cancer can be performed with various imaging modalities, however, positron emission tomography (PET) is a sensitive and non-invasive molecular imaging technology and this review will focus on PET molecular imaging of breast cancer, such as FDG-PET, FLT-PET, hormone receptor PET, and anti-HER2 PET.

引用

页码：24 / 32

页数：9

共 50 条

[41] Quantifying the Abscopal Effect in Breast Cancer Using Granzyme B PET Imaging
Zhang, Y.
Larimer, B.
Yang, E. S.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E531 - E532
[42] Breast imaging technology: Probing physiology and molecular function using optical imaging - applications to breast cancer
Vasilis Ntziachristos
Britton Chance
Breast Cancer Research, 3
[43] Breast cancer - II - Overview of the current status of PET in breast cancer imaging
Wahl, RL
QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 1998, 42 (01): : 1 - 7
[44] Molecular Imaging of Cancer with Radiolabeled Peptides and PET
Vavere, Amy L.
Rossin, Raffaella
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (05) : 462 - 475
[45] Molecular Imaging of Prostate Cancer: PET Radiotracers
Jadvar, Hossein
AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (02) : 278 - 291
[46] Prone PET/CT using an MRI coil for integrated PET-MRI breast cancer imaging
Vogel, W. V.
Rooze, L.
Straver, M. E.
Peeters, M. Vrancken
Siedschlag, C.
Olmos, R. A. Valdes
Gilhuijs, K.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S257 - S257
[47] Improving PET imaging for breast cancer using virtual pinhole PET half-ring insert
Mathews, Aswin John
Komarov, Sergey
Wu, Heyu
O'Sullivan, Joseph A.
Tai, Yuan-Chuan
PHYSICS IN MEDICINE AND BIOLOGY, 2013, 58 (18): : 6407 - 6427
[48] PET and PET-CT Imaging in Treatment Monitoring of Breast Cancer
Kumar, Rakesh
Chawla, Madhavi
Basu, Sandip
Alavi, Abass
PET CLINICS, 2009, 4 (04) : 359 - 369
[49] Molecular Imaging of Biomarkers in Breast Cancer
Ulaner, Gary A.
Riedl, Chris C.
Dickler, Maura N.
Jhaveri, Komal
Pandit-Taskar, Neeta
Weber, Wolfgang
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 : 53S - 59S
[50] Radioisotopic molecular imaging in breast cancer
Spanu, A.
Madeddu, G.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S45 - S45

← 1 2 3 4 5 →